PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30389790-11	2018	We propose that accumulation of G3M9-bearing glycoproteins is toxic and at least partially responsible for defects observed in MOGS-CDG.	cdg	132-135	mannosyl-oligosaccharide glucosidase	Homo sapiens	127-131	
33058492-0	2021	Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.	cdg	35-38	mannosyl-oligosaccharide glucosidase	Homo sapiens	67-71	
33058492-9	2021	We report the oldest-known MOGS-CDG patient and broaden the neurological phenotype of this CDG.	cdg	32-35	mannosyl-oligosaccharide glucosidase	Homo sapiens	27-31	
24716661-1	2014	Genetic defects in MOGS, the gene encoding mannosyl-oligosaccharide glucosidase (the first enzyme in the processing pathway of N-linked oligosaccharide), cause the rare congenital disorder of glycosylation type IIb (CDG-IIb), also known as MOGS-CDG.	cdg	216-219	mannosyl-oligosaccharide glucosidase	Homo sapiens	19-23	
24716661-1	2014	Genetic defects in MOGS, the gene encoding mannosyl-oligosaccharide glucosidase (the first enzyme in the processing pathway of N-linked oligosaccharide), cause the rare congenital disorder of glycosylation type IIb (CDG-IIb), also known as MOGS-CDG.	cdg	216-219	mannosyl-oligosaccharide glucosidase	Homo sapiens	43-79